GSK shelves cough drug acquired in $2B deal
admin London-based pharmaceutical giant GSK has announced the discontinuation of its camlipixant development program, a P2X3...
fda
Biopharma Sector Roiled by Escalating COVID Vaccine Patent Battles as Promising New Therapies and AI Partnerships Reshape Industry Landscape
The biopharmaceutical industry finds itself navigating a complex legal and scientific terrain this week, marked...
Jasper Therapeutics Secures Lifeline and Expands Pipeline Through Strategic Merger with Kira Pharmaceuticals and $132 Million Private Financing
In a pivotal move to reverse its flagging fortunes, Jasper Therapeutics, a biotechnology company that...
FDA Approves Merck’s Lipfendra, the First Oral PCSK9 Inhibitor, Reigniting Debate on Accelerated Review Programs
The U.S. Food and Drug Administration (FDA) has granted approval to Lipfendra, a groundbreaking new...
Veradermics keeps ‘momentum going’ as baldness drug helps women with hair loss
Boston, MA – Veradermics, a burgeoning biopharmaceutical firm, has announced groundbreaking results from its Phase...
Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics
Pharmaceutical giant Eli Lilly has announced its intention to acquire AtaiBeckley, a leading specialist in...
Celcuity Secures Landmark FDA Approval for Breast Cancer Drug Revtorpyk Amidst Investor Concerns Over Launch Delay and Prescribing Information
Celcuity, a burgeoning player in the biopharmaceutical sector, marked a pivotal milestone on Tuesday, July...
UK Pharma Giants Deepen Strategic Alliances with Chinese Counterparts Amidst Intensifying Geopolitical Scrutiny
London, UK – July 8, 2026 – In a series of significant strategic moves that...
Bionyra, a biotechnology company building new biologics to treat immune diseases, emerged from stealth Monday with $165 million.
The biotech landscape witnessed a significant entry this week as Bionyra, a meticulously incubated biotechnology...
Pfizer CFO to step down; Denali sells a regulatory fast-pass
The dynamic biopharmaceutical sector witnessed a series of significant developments this week, reflecting ongoing shifts...
